Nov 12 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2021 Sep 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8 mln 15 mln 328 mln
(-44.9 pct) (-91.0 pct) (+185.3 pct)
Operating loss 675 mln loss 958 mln loss 766 mln
Recurring loss 688 mln loss 978 mln loss 778 mln
Net loss 677 mln loss 981 mln loss 781 mln
EPS loss 32.93 yen loss 63.06 yen loss 34.21 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T